Search

Your search keyword '"COECKE SANDRA"' showing total 440 results

Search Constraints

Start Over You searched for: Author "COECKE SANDRA" Remove constraint Author: "COECKE SANDRA"
440 results on '"COECKE SANDRA"'

Search Results

2. Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility

4. OECD harmonised template 201: Structuring and reporting mechanistic information to foster the integration of new approach methodologies for hazard and risk assessment of chemicals

5. Building an Adverse Outcome Pathway network for COVID-19

8. Metabolites in the regulatory risk assessment of pesticides in the EU

9. Taking the leap toward human-specific nonanimal methodologies: The need for harmonizing global policies for microphysiological systems

10. Establishing a systematic framework to characterise in vitro methods for human hepatic metabolic clearance

13. Meeting Report: Validation of Toxicogenomics-Based Test Systems: ECVAM-ICCVAM/NICEATM Considerations for Regulatory Use

14. Practical Aspects of Designing and Conducting Validation Studies Involving Multi-study Trials

16. International Harmonization and Cooperation in the Validation of Alternative Methods

20. Metabolites in the regulatory risk assessment of pesticides in the EU

22. ECVAM and New Technologies for Toxicity Testing

23. Factors Modulating COVID-19 : A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework

24. Factors Modulating COVID-19

25. The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19

26. Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework

28. A New Approach Method to Study Thyroid Hormone Disruption: Optimization and Standardization of an Assay to Assess the Inhibition of DIO1 Enzyme in Human Liver Microsomes

29. Advances in Animal Models and Cutting-Edge Research in Alternatives: Proceedings of the Third International Conference on 3Rs Research and Progress, Vishakhapatnam, 2022.

31. Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework

35. COVID-19 through adverse outcome pathways: building networks to better understand the disease: report of the 3rd CIAO AOP design workshop

36. COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design Workshop

38. New approach methodologies (NAMs) for human-relevant biokinetics predictions

39. Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0)

40. COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design Workshop

44. Considerations in the Development of In Vitro Toxicity Testing Methods Intended for Regulatory Use

46. Non-animal Methods in Science and Regulation: EURL ECVAM Status Report 2020

47. Establishing the scientific validity of complex in vitro models: Results of a EURL ECVAM survey

48. Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010

Catalog

Books, media, physical & digital resources